Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy conceptAlessandro Vitale, Francesco Paolo Russo, Martina Gambato et al.|The Lancet Oncology|2023Cited by 184
Delisting <scp>HCV</scp>‐infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delistingGiovanni Perricone, L Belli, Christophe Duvoux et al.|Liver International|2018Cited by 76
The optimal timing of hepatitis C therapy in liver transplant‐eligible patients: Cost‐effectiveness analysis of new opportunitiesPaolo Angelo Cortesi, Mario Strazzabosco, L Belli et al.|Journal of Viral Hepatitis|2018Cited by 31
The percentage of patients with HCV infection in need of a liver transplant is rapidly declining while their survival after transplantation is improving: A study based on European liver transplant registryGiovanni Perricone, L Belli, Chiara Mazzarelli et al.|Journal of Hepatology|2018Cited by 1
Changes of indications for liver transplantation in the era of direct acting antiviral therapy in EuropeGiovanni Perricone, L Belli, R. Viganò et al.|Digestive and Liver Disease|2018Cited by 0